Global brachytherapy market expected to generate revenue of around USD 441 million by end of 2025, growing at a CAGR of around 4% between 2019 and 2025. Increasing awareness, technological advancement in the treatment of cancer, and extensive R&D will drive the brachytherapy market growth over the forecast period.

Sarasota, FL -- (SBWire) -- 02/11/2019 --Zion Market Research has published a new report titled "Childcare Management Software Market by Deployment (On-premise and Cloud-Based), by Solution(Family and Child Data Management, Time and Activity Management, Nutrition Management, Attendance Tracker, Employee Data Management, Payroll, Accounting, and Others), and by End-user(Parents, Daycare Centers, and Play Schools): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2026". According to the report, global brachytherapy market was valued at approximately USD 334 million in 2018 and is expected to generate revenue of around USD 441 million by end of 2025, growing at a CAGR of around 4% between 2019 and 2025.

Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/brachytherapy-market

Brachytherapy is referring to broadly varying processes coupled with changing degrees of invasiveness. Brachytherapy also termed as internal radiation therapy, allows a physician to use a higher dose of radiation for the treatment of smaller area and in a short timespan as compared to the external beam radiation treatment. It is a type of radiation therapy which is used for the treatment of cancer. Radiation therapies generally comprise of different types of energy termed as ionizing radiation, which is used to target and shrink tumors and kill cancer cells. External beam radiation therapy (EBRT) encompasses high-energy X-ray stream of light produced by a machine that is focused at the tumor from outside the body. The brachytherapy includes the introduction of radioactive material right inside or next to the tumor area.

Cancer is the second most common cause of death in the U.S. According to the American Cancer Society, in 2017, around 600,920 American population died due to cancer. Cancer is one of the foremost reasons for mortality worldwide. There are various types of cancer such as prostate cancer, lung cancer, skin cancer, breast cancer, and colon cancer. Among them, breast cancer is one of the leading types of cancer-causing death, especially in women. Majority of cancer cases are detected and diagnosed when the tumor is seen or felt. Moreover, more than 70% of deaths related to cancer occur in underdeveloped economies in low and middle-income population. Thus, increasing awareness, technological advancement in the treatment of cancer, and extensive R&D will drive the brachytherapy market growth over the forecast period.

The brachytherapy market is segmented on the basis of technique, application, and by end-user. By technique, the global brachytherapy market is segmented into high dose rate and low dose rate. The high dose rate segment accounted for the major share in the global brachytherapy market in 2017. The growth can be attributed to technological developments, the introduction of novel products, and massive applications.

Cervical cancer, prostate cancer, breast cancer, skin cancer, and others are the key applications of the brachytherapy market. The prostate cancer segment dominated the market in terms of revenue in 2017. On the other hand, the breast cancer segment is anticipated to register the highest CAGR in the global brachytherapy market, owing to the increasing prevalence of breast cancer across the globe.

On the basis of end-user, the global brachytherapy market is segmented into hospitals and oncology treatment centers. The hospital's segment is estimated to dominate the global brachytherapy market during the forecast period. The oncology treatment centers segment is anticipated to grow with highest CAGR in global brachytherapy market.

North America, Asia Pacific, Europe, Middle East & Africa, and Latin America are key regional segments of the global brachytherapy market. North America is anticipated to remain the leading region over the forecast period. Growth in the region is attributed to the high prevalence of cancer and the adoption of advanced diagnostic techniques. According to the National Cancer Institute, in the U.S., approximately 1,735,350 new cases of cancer were estimated in 2018. Europe holds the second largest global market share. The Asia Pacific is expected to be the fasted growing region in the brachytherapy market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show considerable growth for the brachytherapy market in the years to come.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/brachytherapy-market

Some of the key players in global brachytherapy market include Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Carl Zeiss Meditec AG, Argon Medical Devices Inc., Panacea Medical Technologies, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, and Varian Medical Systems, Inc., among others.

Global Brachytherapy Market: Technique Segment Analysis

High Dose Rate
Low Dose Rate

Global Brachytherapy Market: Application Segment Analysis

Cervical Cancer
Prostate Cancer
Breast Cancer
Skin Cancer
Others

Global Brachytherapy Market: End-User Segment Analysis

Hospitals
Oncology Treatment Centers

Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/brachytherapy-market

Global Brachytherapy Market: Regional Segment Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa